Report Detail
Global PRRS Vaccines Market Insights, Forecast to 2025
- RnM3367855 |
- 30 April, 2019 |
- Global |
- 124 Pages |
- QYResearch |
- Machinery & Equipment
There are two types of PRRS vaccines that are commercially available. One is a modified-live virus (MLV) vaccine and the other is a killed virus (KV) vaccine. PRRS MLV vaccine is well recognized for its protective efficacy against PRRSV that are genetically homologous to the vaccine virus.
The PRRS Vaccines market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for PRRS Vaccines.
This report presents the worldwide PRRS Vaccines market size (value, production and consumption), splits the breakdown (data status 2014-2019 and forecast to 2025), by manufacturers, region, type and application.
This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
The following manufacturers are covered in this report:
CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Zoetis
PRRS Vaccines Breakdown Data by Type
Live Vaccines
Killed Vaccines
PRRS Vaccines Breakdown Data by Application
Government Tender
Market Sales
PRRS Vaccines Production by Region
United States
Europe
China
Japan
Other Regions
PRRS Vaccines Consumption by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives are:
To analyze and research the global PRRS Vaccines status and future forecast，involving, production, revenue, consumption, historical and forecast.
To present the key PRRS Vaccines manufacturers, production, revenue, market share, and recent development.
To split the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of PRRS Vaccines :
History Year: 2014 - 2018
Base Year: 2018
Estimated Year: 2019
Forecast Year: 2019 - 2025
This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of PRRS Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 PRRS Vaccines Product
- 1.2 Key Market Segments in This Study
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global PRRS Vaccines Market Size Growth Rate by Type
- 1.4.2 Live Vaccines
- 1.4.3 Killed Vaccines
- 1.5 Market by Application
- 1.5.1 Global PRRS Vaccines Market Size Growth Rate by Application
- 1.5.2 Government Tender
- 1.5.3 Market Sales
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global PRRS Vaccines Market Size
- 2.1.1 Global PRRS Vaccines Revenue 2014-2025
- 2.1.2 Global PRRS Vaccines Production 2014-2025
- 2.2 PRRS Vaccines Growth Rate (CAGR) 2019-2025
- 2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Key PRRS Vaccines Manufacturers
- 2.3.2.1 PRRS Vaccines Manufacturing Base Distribution, Headquarters
- 2.3.2.2 Manufacturers PRRS Vaccines Product Offered
- 2.3.2.3 Date of Manufacturers Enter into PRRS Vaccines Market
- 2.4 Key Trends for PRRS Vaccines Markets & Products
3 Market Size by Manufacturers
- 3.1 PRRS Vaccines Production by Manufacturers
- 3.1.1 PRRS Vaccines Production by Manufacturers
- 3.1.2 PRRS Vaccines Production Market Share by Manufacturers
- 3.2 PRRS Vaccines Revenue by Manufacturers
- 3.2.1 PRRS Vaccines Revenue by Manufacturers (2014-2019)
- 3.2.2 PRRS Vaccines Revenue Share by Manufacturers (2014-2019)
- 3.3 PRRS Vaccines Price by Manufacturers
- 3.4 Mergers & Acquisitions, Expansion Plans
4 PRRS Vaccines Production by Regions
- 4.1 Global PRRS Vaccines Production by Regions
- 4.1.1 Global PRRS Vaccines Production Market Share by Regions
- 4.1.2 Global PRRS Vaccines Revenue Market Share by Regions
- 4.2 United States
- 4.2.1 United States PRRS Vaccines Production
- 4.2.2 United States PRRS Vaccines Revenue
- 4.2.3 Key Players in United States
- 4.2.4 United States PRRS Vaccines Import & Export
- 4.3 Europe
- 4.3.1 Europe PRRS Vaccines Production
- 4.3.2 Europe PRRS Vaccines Revenue
- 4.3.3 Key Players in Europe
- 4.3.4 Europe PRRS Vaccines Import & Export
- 4.4 China
- 4.4.1 China PRRS Vaccines Production
- 4.4.2 China PRRS Vaccines Revenue
- 4.4.3 Key Players in China
- 4.4.4 China PRRS Vaccines Import & Export
- 4.5 Japan
- 4.5.1 Japan PRRS Vaccines Production
- 4.5.2 Japan PRRS Vaccines Revenue
- 4.5.3 Key Players in Japan
- 4.5.4 Japan PRRS Vaccines Import & Export
- 4.6 Other Regions
- 4.6.1 South Korea
- 4.6.2 India
- 4.6.3 Southeast Asia
5 PRRS Vaccines Consumption by Regions
- 5.1 Global PRRS Vaccines Consumption by Regions
- 5.1.1 Global PRRS Vaccines Consumption by Regions
- 5.1.2 Global PRRS Vaccines Consumption Market Share by Regions
- 5.2 North America
- 5.2.1 North America PRRS Vaccines Consumption by Application
- 5.2.2 North America PRRS Vaccines Consumption by Countries
- 5.2.3 United States
- 5.2.4 Canada
- 5.2.5 Mexico
- 5.3 Europe
- 5.3.1 Europe PRRS Vaccines Consumption by Application
- 5.3.2 Europe PRRS Vaccines Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 UK
- 5.3.6 Italy
- 5.3.7 Russia
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific PRRS Vaccines Consumption by Application
- 5.4.2 Asia Pacific PRRS Vaccines Consumption by Countries
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Indonesia
- 5.4.9 Thailand
- 5.4.10 Malaysia
- 5.4.11 Philippines
- 5.4.12 Vietnam
- 5.5 Central & South America
- 5.5.1 Central & South America PRRS Vaccines Consumption by Application
- 5.5.2 Central & South America PRRS Vaccines Consumption by Country
- 5.5.3 Brazil
- 5.6 Middle East and Africa
- 5.6.1 Middle East and Africa PRRS Vaccines Consumption by Application
- 5.6.2 Middle East and Africa PRRS Vaccines Consumption by Countries
- 5.6.3 GCC Countries
- 5.6.4 Egypt
- 5.6.5 South Africa
6 Market Size by Type
- 6.1 Global PRRS Vaccines Production by Type
- 6.2 Global PRRS Vaccines Revenue by Type
- 6.3 PRRS Vaccines Price by Type
7 Market Size by Application
- 7.1 Overview
- 7.2 Global PRRS Vaccines Breakdown Dada by Application
- 7.2.1 Global PRRS Vaccines Consumption by Application
- 7.2.2 Global PRRS Vaccines Consumption Market Share by Application (2014-2019)
8 Manufacturers Profiles
- 8.1 CAHIC
- 8.1.1 CAHIC Company Details
- 8.1.2 Company Overview
- 8.1.3 CAHIC PRRS Vaccines Production Revenue and Gross Margin (2014-2019)
- 8.1.4 CAHIC PRRS Vaccines Product Description
- 8.1.5 CAHIC Recent Development
- 8.2 Merial
- 8.2.1 Merial Company Details
- 8.2.2 Company Overview
- 8.2.3 Merial PRRS Vaccines Production Revenue and Gross Margin (2014-2019)
- 8.2.4 Merial PRRS Vaccines Product Description
- 8.2.5 Merial Recent Development
- 8.3 MSD Animal Health
- 8.3.1 MSD Animal Health Company Details
- 8.3.2 Company Overview
- 8.3.3 MSD Animal Health PRRS Vaccines Production Revenue and Gross Margin (2014-2019)
- 8.3.4 MSD Animal Health PRRS Vaccines Product Description
- 8.3.5 MSD Animal Health Recent Development
- 8.4 Chopper Biology
- 8.4.1 Chopper Biology Company Details
- 8.4.2 Company Overview
- 8.4.3 Chopper Biology PRRS Vaccines Production Revenue and Gross Margin (2014-2019)
- 8.4.4 Chopper Biology PRRS Vaccines Product Description
- 8.4.5 Chopper Biology Recent Development
- 8.5 Ceva
- 8.5.1 Ceva Company Details
- 8.5.2 Company Overview
- 8.5.3 Ceva PRRS Vaccines Production Revenue and Gross Margin (2014-2019)
- 8.5.4 Ceva PRRS Vaccines Product Description
- 8.5.5 Ceva Recent Development
- 8.6 ChengDu Tecbond
- 8.6.1 ChengDu Tecbond Company Details
- 8.6.2 Company Overview
- 8.6.3 ChengDu Tecbond PRRS Vaccines Production Revenue and Gross Margin (2014-2019)
- 8.6.4 ChengDu Tecbond PRRS Vaccines Product Description
- 8.6.5 ChengDu Tecbond Recent Development
- 8.7 Veterinary
- 8.7.1 Veterinary Company Details
- 8.7.2 Company Overview
- 8.7.3 Veterinary PRRS Vaccines Production Revenue and Gross Margin (2014-2019)
- 8.7.4 Veterinary PRRS Vaccines Product Description
- 8.7.5 Veterinary Recent Development
- 8.8 Ringpu Biology
- 8.8.1 Ringpu Biology Company Details
- 8.8.2 Company Overview
- 8.8.3 Ringpu Biology PRRS Vaccines Production Revenue and Gross Margin (2014-2019)
- 8.8.4 Ringpu Biology PRRS Vaccines Product Description
- 8.8.5 Ringpu Biology Recent Development
- 8.9 Qilu Animal
- 8.9.1 Qilu Animal Company Details
- 8.9.2 Company Overview
- 8.9.3 Qilu Animal PRRS Vaccines Production Revenue and Gross Margin (2014-2019)
- 8.9.4 Qilu Animal PRRS Vaccines Product Description
- 8.9.5 Qilu Animal Recent Development
- 8.10 DHN
- 8.10.1 DHN Company Details
- 8.10.2 Company Overview
- 8.10.3 DHN PRRS Vaccines Production Revenue and Gross Margin (2014-2019)
- 8.10.4 DHN PRRS Vaccines Product Description
- 8.10.5 DHN Recent Development
- 8.11 CAVAC
- 8.12 Komipharm
- 8.13 Agrovet
- 8.14 Bioveta
- 8.15 Jinyu Bio-Technology
- 8.16 Institutul Pasteur
- 8.17 MVP
- 8.18 Tecon
- 8.19 Zoetis
9 Production Forecasts
- 9.1 PRRS Vaccines Production and Revenue Forecast
- 9.1.1 Global PRRS Vaccines Production Forecast 2019-2025
- 9.1.2 Global PRRS Vaccines Revenue Forecast 2019-2025
- 9.2 PRRS Vaccines Production and Revenue Forecast by Regions
- 9.2.1 Global PRRS Vaccines Revenue Forecast by Regions
- 9.2.2 Global PRRS Vaccines Production Forecast by Regions
- 9.3 PRRS Vaccines Key Producers Forecast
- 9.3.1 United States
- 9.3.2 Europe
- 9.3.3 China
- 9.3.4 Japan
- 9.4 Forecast by Type
- 9.4.1 Global PRRS Vaccines Production Forecast by Type
- 9.4.2 Global PRRS Vaccines Revenue Forecast by Type
10 Consumption Forecast
- 10.1 PRRS Vaccines Consumption Forecast by Application
- 10.2 PRRS Vaccines Consumption Forecast by Regions
- 10.3 North America Market Consumption Forecast
- 10.3.1 North America PRRS Vaccines Consumption Forecast by Regions 2019-2025
- 10.3.2 United States
- 10.3.3 Canada
- 10.3.4 Mexico
- 10.4 Europe Market Consumption Forecast
- 10.4.1 Europe PRRS Vaccines Consumption Forecast by Regions 2019-2025
- 10.4.2 Germany
- 10.4.3 France
- 10.4.4 UK
- 10.4.5 Italy
- 10.4.6 Russia
- 10.5 Asia Pacific Market Consumption Forecast
- 10.5.1 Asia Pacific PRRS Vaccines Consumption Forecast by Regions 2019-2025
- 10.5.2 China
- 10.5.3 Japan
- 10.5.4 South Korea
- 10.5.5 India
- 10.5.6 Australia
- 10.5.7 Indonesia
- 10.5.8 Thailand
- 10.5.9 Malaysia
- 10.5.10 Philippines
- 10.5.11 Vietnam
- 10.6 Central & South America Market Consumption Forecast
- 10.6.1 Central & South America PRRS Vaccines Consumption Forecast by Regions 2019-2025
- 10.6.2 Brazil
- 10.7 Middle East and Africa Market Consumption Forecast
- 10.7.1 Middle East and Africa PRRS Vaccines Consumption Forecast by Regions 2019-2025
- 10.7.2 GCC Countries
- 10.7.3 Egypt
- 10.7.4 South Africa
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 PRRS Vaccines Sales Channels
- 11.2.2 PRRS Vaccines Distributors
- 11.3 PRRS Vaccines Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
- 12.1 Market Opportunities and Drivers
- 12.2 Market Challenges
- 12.3 Market Risks/Restraints
13 Key Findings in the Global PRRS Vaccines Study
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on PRRS Vaccines . Industry analysis & Market Report on PRRS Vaccines is a syndicated market report, published as Global PRRS Vaccines Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of PRRS Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
